Further GSEA analysis of tumor hallmarks indicated that oncogenic pathways, including IL6/JAK/STAT3 signaling, KRAS signaling, and Wnt/β‐catenin signaling pathway were engaged in the high‐risk group (Figure 5B). This evidence concerns the gene KRAS and neoplasm.